Suggestions
Maroof Ahmed
Co-founder and COO at Quit Genius - Forbes 30 Under 30 - YC W18 - Medical Doctor
Maroof Ahmed is the COO and Co-founder of Pelago (formerly known as Quit Genius), a virtual clinic for substance use management based in New York.12 He has been in this role since April 2017, overseeing operations and strategic initiatives for the company.12
Background and Education
Maroof holds a Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) from Imperial College London, which he completed between 2011 and 2017.1 He also earned a Bachelor's Degree in Management with First Class Honours from Imperial College Business School in 2014-2015.1
Career Highlights
- Pelago (formerly Quit Genius): Co-founded in April 2017, Pelago has grown to become a leading virtual clinic for substance use management, helping over 750,000 members.12
- Interview Doctors: Prior to Pelago, Maroof was the CEO and Founder of Interview Doctors from January 2015 to January 2018, providing tutoring services for prospective medical students.1
- Y Combinator: Participated in the W18 batch with Quit Genius in 2018.1
Achievements and Recognition
- Awarded the Imperial College Business School Prize for Best Group Research Project Performance.1
- Received the Governor's Prize for the highest overall mark in the Intercalated BSc programme at Imperial College Business School.1
- Named to the Dean's List 2014/2015 at Imperial College Business School.1
Company Growth and Funding
Under Maroof's leadership, Pelago has raised significant funding, including a $64 million Series B round in 20215 and a more recent $58 million Series C round.4 The company has expanded its services to cover tobacco, alcohol, and opioid addictions, using cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT).13
Maroof Ahmed's work at Pelago is driven by a personal motivation, inspired by the loss of his uncle to addiction.4 He is committed to making substance use support accessible and approachable, with a focus on judgment-free, stigma-free messaging and tailored support for individuals struggling with substance use.4
Highlights



